Empagliflozin in Black Versus White Patients With Heart Failure: Analysis of EMPEROR-Pooled

Author:

Verma Subodh1ORCID,Dhingra Nitish K.1,Butler Javed23ORCID,Anker Stefan D.4ORCID,Pedro Ferreira João56ORCID,Filippatos Gerasimos7ORCID,Januzzi James L.8ORCID,Lam Carolyn S.P.9ORCID,Sattar Naveed10ORCID,Pfarr Egon11ORCID,Nordaby Matias12,Brueckmann Martina1213ORCID,Pocock Stuart J.14,Zannad Faiez5ORCID,Packer Milton1516ORCID,

Affiliation:

1. Division of Cardiac Surgery, St Michael’s Hospital, University of Toronto, Canada (S.V., N.K.D.).

2. Baylor Scott and White Research Institute, Dallas, TX (J.B.).

3. Department of Medicine, University of Mississippi School of Medicine, Jackson (J.B.).

4. Department of Cardiology and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Germany (S.D.A.).

5. Université de Lorraine, Inserm, Centre d’Investigations Cliniques, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France (J.P.F., F.Z.).

6. Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Portugal (J.P.F.).

7. National and Kapodistrian University of Athens School of Medicine, Athens University Hospital Attikon, Greece (G.F.).

8. Division of Cardiology, Harvard Medical School and Massachusetts General Hospital, Boston (J.L.J.).

9. National Heart Centre Singapore, Duke-NUS Medical School (C.S.P.L.).

10. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, UK (N.S.).

11. Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany (E.P.).

12. Boehringer Ingelheim International GmbH, Ingelheim, Germany (M.N., M.B.).

13. First Department of Medicine, Faculty of Medicine Mannheim, University of Heidelberg, Germany (M.B.).

14. Department of Medical Statistics, London School of Hygiene and Tropical Medicine, United Kingdom (S.J.P.).

15. Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX (M.P.).

16. Imperial College, London, United Kingdom (M.P.).

Funder

Boehringer Ingeleheim-Lilly Diabetes Alliance

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3